These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11267941)

  • 1. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
    Takenoyama M; Yoshino I; Eifuku R; So T; Imahayashi S; Sugaya M; Yasuda M; Inoue M; Ichiyoshi Y; Osaki T; Nagashima A; Nomoto K; Yasumoto K
    Jpn J Cancer Res; 2001 Mar; 92(3):309-15. PubMed ID: 11267941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer.
    Yoshino I; Takenoyama M; Fujie H; Hanagiri T; Yoshimatsu T; Imabayashi S; Eifuku R; Ogami A; Yano K; Osaki T; Nakanishi R; Ichiyoshi Y; Nomoto K; Yasumoto K
    Jpn J Cancer Res; 1997 Aug; 88(8):743-9. PubMed ID: 9330606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of autologous tumor-specific T cell clones from a patient with adenosquamous carcinoma of the lung.
    So T; Takenoyama M; Sugaya M; Yasuda M; Eifuku R; Yoshimatsu T; Hanagiri T; Oyama T; Kodate M; Osaki T; Yasumoto K
    Jpn J Clin Oncol; 2001 Jul; 31(7):311-7. PubMed ID: 11518743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.
    Takenoyama M; Yoshino I; Fujie H; Hanagiri T; Yoshimatsu T; Imabayashi S; Eifuku R; Nomoto K; Yasumoto K
    Jpn J Cancer Res; 1998 Jan; 89(1):60-6. PubMed ID: 9510477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on generation of cytotoxic T lymphocytes against oral squamous carcinoma by gene-transduction of a co-stimulatory molecule, CD80].
    Mogi S
    Kokubyo Gakkai Zasshi; 1999 Mar; 66(1):107-17. PubMed ID: 10332153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
    Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer.
    Bixby DL; Yannelli JR
    Int J Cancer; 1998 Dec; 78(6):685-94. PubMed ID: 9833760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
    Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interleukin-12 on the induction of cytotoxic T lymphocytes from the regional lymph node lymphocytes of patients with lung adenocarcinoma.
    Hanagiri T; Yoshino I; Takenoyama M; So T; Fujie H; Imabayashi S; Eifuku R; Yoshimatsu T; Osaki T; Nakanishi R; Ichiyoshi Y; Nagashima A; Nomoto K; Yasumoto K
    Jpn J Cancer Res; 1998 Feb; 89(2):192-8. PubMed ID: 9548447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells.
    Mackensen A; Wittnebel S; Veelken H; Noppen C; Spagnoli GC; Lindermann A
    Eur Cytokine Netw; 1999 Sep; 10(3):329-36. PubMed ID: 10477389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.
    Hiraki A; Ono T; Tanaka M; Kiura K; Ueoka H; Kawai H; Harada M; Nakayama E; Noguchi Y
    Anticancer Res; 2001; 21(4A):2561-7. PubMed ID: 11724322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
    J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
    Matsumoto K; Anasetti C
    Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells.
    Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N
    J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.
    Kuroda K; Takenoyama M; Baba T; Shigematsu Y; Shiota H; Ichiki Y; Yasuda M; Uramoto H; Hanagiri T; Yasumoto K
    Cancer Sci; 2010 Jan; 101(1):46-53. PubMed ID: 19799608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells.
    Kaufmann AM; Gissmann L; Simms P; Schreckenberger C; Qiao L
    Immunobiology; 2000 Nov; 202(4):339-52. PubMed ID: 11131151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y; Hanagiri T; Takenoyama M; Fukuyama T; Mizukami M; So T; Ichiki Y; Sugaya M; Sugio K; Yasumoto K
    Clin Cancer Res; 2005 Jul; 11(14):5265-72. PubMed ID: 16033845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lung.
    Sugaya M; Takenoyama M; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    Int J Cancer; 2007 Mar; 120(5):1055-62. PubMed ID: 17131342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.